A preclinical assessment of afatinib-treated HER2(+) gastric malignancies using Zr-89 trastuzumab

被引：0
|
作者：
Viola-Villegas, Nerissa [1 ]
Janjigian, Yelena [2 ]
Gomes-DaGama, Erica [2 ]
Holland, Jason [1 ]
de Stanchina, Elisa [3 ]
Lewis, Jason [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Radiol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Med, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Antitumor Assessment Core Facil, New York, NY 10021 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1105
引用
收藏
页数：2
相关论文
共 50 条
  • [41] 89Zr-Trastuzumab P1-414T/CT for Prediction of Response to HER2-targeted therapy in Patientswith HER2 Mutant Lung Cancer: Exploratory Phase 2 Trial
    Ulaner, Gary
    Offin, Michael
    Scaltriti, Maurizio
    Myers, Mackenzie
    Venkatesh, Aishwarya
    Panora, Elizabeth
    Kris, Mark
    Rudin, Charles
    Arcila, Maria
    Lyashchenko, Serge
    Lewis, Jason
    Li, Bob
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [42] 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
    Bensch, Frederike
    Brouwers, A. H.
    Lub-de Hooge, M. N.
    de Jong, J. R.
    van der Vegt, B.
    Sleijfer, S.
    de Vries, E. G. E.
    Schroeder, C. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (13) : 2300 - 2306
  • [43] 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
    Frederike Bensch
    A. H. Brouwers
    M. N. Lub-de Hooge
    J. R. de Jong
    B. van der Vegt
    S. Sleijfer
    E. G. E. de Vries
    C. P. Schröder
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2300 - 2306
  • [44] Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy
    Park, Joo-Hwan
    Yeo, Ja Hyun
    Kim, Young Saing
    Park, Inkeun
    Ahn, Hee Kyung
    Shin, Dong Bok
    Lee, Woon-Ki
    Yang, Jun-Young
    Kim, Hyung-Sik
    Sym, Sun Jin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (06): : 232 - 238
  • [45] Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy (vol 50, pg 955, 2015)
    Zhou, Jun
    Peng, Zhi
    Liu, Yi
    Gong, Jifang
    Zhang, Xiaotian
    Lu, Ming
    Gao, Jing
    Li, Yili
    Li, Yanyan
    Shen, Lin
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (05) : 509 - 510
  • [46] Detection of HER2-positive metastases n patients with HER2-negative primary breast cancer using 89Zr-DFO-trastuzumab PET/CT
    Ulaner, Gary
    Hyman, David
    Ross, Dara
    Corben, Adriana
    Chandarlapaty, Sarat
    Goldfarb, Shari
    Heather, Mcarthur
    Erinjeri, Joseph
    Solomon, Stephen
    Kolb, Hartmuth
    Lyashchenko, Serge
    Lewis, Jason
    Carrasquillo, Jorge
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [47] Effects of Extended Fixation on Advanced Gastric Cancer HER2 Status Assessment Using IHC and FISH
    Kondo, Junya
    Yoshino, Shigefumi
    Iida, Michihisa
    Takeda, Shigeru
    Nakashima, Chiyo
    Watanabe, Yusaku
    Nishiyama, Mitsuo
    Tokumitsu, Yukio
    Shindo, Yoshitaro
    Nishimura, Taku
    Suzuki, Nobuaki
    Hoshii, Yoshinobu
    Itoh, Hiroshi
    Nagano, Hiroaki
    ANTICANCER RESEARCH, 2024, 44 (02) : 621 - 630
  • [48] Quantitative Analysis of HER2 Amplification by Droplet Digital PCR in the Follow-Up of Gastric Cancer Patients Being Treated with Trastuzumab after Surgery
    Liu, Yanzhuo
    Yang, Maozhu
    Jiang, Tao
    Lan, Chunbin
    Yuan, Hao
    Li, Guiquan
    Jia, Guiqing
    Wang, Kang
    Zhao, Gaoping
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [49] A case of unresectable Stage IV HER2-positive advanced gastric cancer treated by using trastuzumab combined with SOX
    Horie, Tatsuo
    Mizumoto, Kazuo
    Sakano, Sigeru
    Horie, Miyako
    Ishibashi, Hirokazu
    Takahashi, Masahiko
    Honda, Satoshi
    Noso, Yoshihiro
    ANNALS OF ONCOLOGY, 2015, 26 : 134 - 135
  • [50] Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment
    Xu, Chen
    Liu, Yalan
    Jiang, Dongxian
    Ge, Xiaowen
    Huang, Jie
    Su, Jieakesu
    Zhang, Xue
    Lu, Shaohua
    Ji, Yuan
    Hou, Jun
    Liu, Tianshu
    Hou, Yingyong
    AGING-US, 2019, 11 (22): : 10052 - 10060
12345